drugset / Trial / NCT01806610
Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, and PK following a single administration of BPS804 in patients with chronic kidney disease stage 5D (CKD-5D) on hemodialysis.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Setrusumab | Monoclonal antibody | — | — |